@ARTICLE{
author={Bosnjak Snezana M,Zilic Ana,Radhakrishnan Venkatraman,Ostwal Vikas,Aapro Matti,Iihara Hirotoshi,Smit Teresa,Gralla Richard J},
year={2025},
title={MASCC antiemetic consensus recommendations: resource-limited settings},
journal={SUPPORTIVE CARE IN CANCER},
volume={33},
number={3},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Schwartzberg Lee Steven,Roeland E,Andric Zoran G,Kowalski Dariusz,Radic J,Voisin Daniel,Rizzi Giada,Navari R,Gralla Richard J,Karthaus Meinolf},
year={2018},
title={Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy},
journal={ANNALS OF ONCOLOGY},
volume={29},
number={7},
pages={1535-1540},
document_type={Article},
} 

@ARTICLE{
author={Bosnjak Snezana M,Gralla Richard J,Schwartzberg Lee Steven},
year={2017},
title={Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists},
journal={SUPPORTIVE CARE IN CANCER},
volume={25},
number={5},
pages={1661-1671},
document_type={Review},
} 

@ARTICLE{
author={Aapro Matti,Jordan Karin,Gralla Richard J,Rizzi Giada,Rossi Giorgia,Palmas Marco,Alyasova Anna V,Lisyanskaya Alla S,Bosnjak Snezana M,Hesketh Paul J},
year={2017},
title={Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients},
journal={JOURNAL OF GERIATRIC ONCOLOGY},
volume={8},
number={1},
pages={56-63},
document_type={Article},
}